Skip to content

Effeccts of Nutritional therapy on quality of life in patients of Chronic liver disease with minimal brain dysfunction -an open label randomized controlled trial.

Effeccts of Nutritional therapy on cognitive functions and health related quality of life in patients of liver cirrhosis with minimal hepatic encephalopathy -an open label randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/07/003851
Enrollment
120
Registered
2013-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Liver cirrhosis patients with minimal hepatic encephalopathy

Interventions

Intervention1: Nutritional therapy: Nutritional therapy will include 30-35kcal/kg and 1.0-1.5 grams of protein/kg body weight according to ESPN guideline for 6 months Control Intervention1: Normal die

Sponsors

GB Pant Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of cirrhosis with minimal hepatic encephalopathy.

Exclusion criteria

Exclusion criteria: History of any episode of overt hepatic encephalopathy. History of shunt surgery or TIPSS Electrolyte imbalance Evidence of infection History of recent use of psychotropic drugs Hepatocellular Carcinoma Severe Medical problem like CHF,Pulmonary disease,neurological and psychiatric disorders History of alcohol intake in last one month History of intake of lactulose rifaximine, LOLA or probiotics inlast one month History of GI bleed in last one month Patient with acute on chronic liver failure

Design outcomes

Primary

MeasureTime frame
To investigate the improvement or worsening in minimal hepatic encephalopathy To investigate the improvement in health related quality of life.Timepoint: at the end of 1,3 and 6 months.

Secondary

MeasureTime frame
Improvement in albumin level,anthrpometry parameters(mid arm circumference, triceps skin fold thickness,hand grip),skeletal muscle mass,body fat mass,percent body fat,creatinine height index and total lymphocyte count,improvement in CTP and MELD score,Hospital admission and mortality.Timepoint: at the end of 1,3 and 6 months

Countries

India

Contacts

Public ContactDr B C Sharma

G.B. Pant Hospital, New Delhi

drbcsharma@hotmail.com9718599203

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 15, 2026